by the betac subunit of interleukin-3 receptor.
Interleukin-3 (IL-3) is a glycoprotein hormone that regulates growth of hematopoietic progenitor cells (18) . IL-3 activates a specific receptor (IL-3R), which is expressed on the surface of its target cells. The IL-3R complex consists of an IL-3-specific ␣ chain and a ␤ common (␤c) chain shared by the granulocyte-macrophage colony-stimulating factor receptor (GM-CSF-R) and the IL-5 receptor (IL-5R) (21, 22, 27, 42) . IL-3R activates multiple signal transduction pathways, including the Ras-Raf-MAP kinase pathway and the JAK-STAT pathway, resulting in the induction of immediate-early genes. How these immediate-early genes couple receptor activation to the biochemical machinery of cell growth and cell cycle progression is not known.
Discrete domains of the cytoplasmic region of the ␤c subunit activate the Ras-Raf-MAP kinase pathway and the JAK-STAT pathway. The distal cytoplasmic domain of ␤c, for example, activates the p21 ras -Raf-MAP kinase pathway (35, 36) . Activation of this pathway results in suppression of apoptosis and induction of the immediate-early genes c-fos and c-jun. The membrane-proximal domain of ␤c, in contrast, is required for activation of the JAK-STAT pathway (50) . Activation of this pathway results in cellular proliferation. In addition, the membrane-proximal region is required for induction of the c-myc gene (45, 46) . IL-3R, like other cytokine receptors, activates a combination of JAK and STAT proteins (10, 17) . JAK kinases are cytoplasmic proteins that constitutively associate with the tails of cytokine receptors and become activated upon receptor-ligand interaction. STAT proteins are latent cytoplasmic transcription factors that are phosphorylated by activated JAK kinases.
Phosphorylated STAT proteins form homo-and hetero-oligomeric complexes and translocate to the nucleus, where they activate transcription of a specific set of genes. STAT complexes bind to STAT binding elements that are found in the 5Ј regulatory sequences of many inducible genes (10) .
Cytokines induce specific proliferative and differentiative responses on their target cells. The biological specificity of each cytokine is determined in part by the activation of unique combinations of JAK kinases and STAT proteins. For instance, IL-3 activates the Janus kinases JAK1 and JAK2 (5, 31) and the STAT proteins STAT5A, STAT5B, and STAT6 (2, 14, 26, 32, 44) . IL-4, on the other hand, activates JAK1 and JAK3 (3, 20, 51) and the STAT protein STAT6 (16) . Additional cytokine specificity is provided by variations in the sizes and sequences of the palindromic STAT binding elements found 5Ј to cytokine-inducible genes (37) . Importantly, other components of cytokine-specific signaling that are distinct from the JAK-STAT pathway remain unidentified. For example, IL-3 and erythropoietin (EPO) both activate JAK2 and STAT5 yet each cytokine induces a unique pattern of immediate-early genes.
In order to identify specific cis-acting regulatory elements that regulate expression of cytokine-inducible genes, we recently utilized the strategy of differential display (23, 24) to isolate IL-3-and EPO-inducible genes. For this purpose, we used Ba/F3-EPO receptor (EPO-R) cells, which have functional receptors for both IL-3 and EPO. While stimulation of IL-3 results in a proliferative signal, stimulation of EPO-R results in erythroid cell-specific differentiation (6) . An IL-3-specific inducible cDNA, DUB-1, was isolated (53) . DUB-1 was identified as a hematopoietic cell-specific immediate-early cDNA that encodes a deubiquitinating enzyme.
In this report, we describe the isolation of a full-length genomic clone for DUB-1 containing its promoter region. Consistent with our cloning strategy, the 5Ј region of the DUB-1 gene was responsive to IL-3 but not to EPO. In addition, DUB-1 was induced by GM-CSF and IL-5, suggesting that it is specifically induced by the shared ␤c subunit. A 112-bp ␤c-specific enhancer region was identified 5Ј to the DUB-1 gene. This enhancer binds two specific protein complexes as demonstrated by electrophoretic mobility shift assays. Further analysis of the DUB-1 cis-acting regulatory sequences and binding proteins should reveal specific determinants of a ␤c-specific signaling pathway.
MATERIALS AND METHODS
Cells and cell culture. Ba/F3 is an IL-3-dependent murine pro-B cell line (28) . Ba/F3-EPO-R cells were generated by stable transfection of Ba/F3 cells with the cDNA encoding the murine EPO-R (8) . Ba/F3-EPO-R cells grow in either murine IL-3 or human EPO (6, 25) . Ba/F3-GM-CSF-R␣ cells were generated by stable transfection of Ba/F3 cells with the cDNA encoding the murine GM-CSF-R␣ (30) . Ba/F3-GM-CSF-R␣ cells grow in either murine IL-3 or murine GM-CSF. Ba/F3-IL-5R␣ cells were generated by stable transfection of Ba/F3 cells with the cDNA encoding the murine IL-5R␣ chain (11, 41, 42) . Ba/F3-IL-5R␣ cells grow in either murine IL-3 or murine IL-5 (30a). The Ba/F3-human IL-4R (hIL-4R) cells grow in either murine IL-3 or hIL-4 (38) . All Ba/F3 subclones were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum and 10% conditioned medium from WEHI-3B cells as a source of murine IL-3.
For induction assays, the various Ba/F3 subclones were washed three times in phosphate-buffered saline, grown at 37ЊC without growth factor for 8 h, and then restimulated with murine IL-3 (Kirin) or with one of several other growth factors for 1 h. Ba/F3-EPO-R cells were restimulated with human EPO (1 pM ϭ 10 mU/ml) (Genetics Institute). Ba/F3-GM-CSF-R␣ cells were restimulated with murine GM-CSF (Prepro Tech Inc.). Ba/F3-IL-5R␣ cells were restimulated with murine IL-5 (R and D Systems). Ba/F3-IL-4R cells were restimulated with IL-4 (Genzyme).
cDNAs and stable transfections. The full-length murine GM-CSF-R␣ cDNA was isolated by reverse transcription-PCR with primers derived from its published sequence (30) . The IL-5R␣ chain (41, 42) was a gift from J. Tavernier. The human GM-CSF-R␣ (hGM-CSF-R␣) cDNA (12) and the wild-type and mutant human ␤c (h␤c) cDNAs (15) were generously supplied by A. Miyajima. Stable transfection of Ba/F3 cells with these cDNAs, using G418 selection, was performed as previously described (9) .
Generation of Ba/F3 cells expressing a chimeric IL-5R␣ subunit. By a PCR strategy (54), a chimeric IL-5R (IL-5R␣-␤IL-3) containing the extracytoplasmic region of IL-5R␣ (41, 42) and the cytoplasmic tail of ␤IL-3 (19) was generated. The IL-5R␣-␤IL-3 chimeric receptor consists of amino acids 1 to 361 of IL-5R␣ fused to amino acids 466 to 882 of ␤IL-3. The cDNA encoding this chimeric receptor was transfected into Ba/F3 cells, and stable Ba/F3 transfectants were analyzed for factor-dependent growth by the XTT assay (9) . Ba/F3(IL-5R␣-␤IL-3) cells grow equally well in IL-3 and IL-5 (30a).
Northern (RNA) analysis. RNA samples (10 to 30 g) were electrophoresed on denaturing formaldehyde gels and blotted onto Duralon UV membranes (Stratagene, La Jolla, Calif.). The indicated cDNA inserts were purified from agarose gels (Qiagen), radiolabeled, and hybridized to the membranes for 1 h at 68ЊC. Hybridized filters were washed at room temperature in 0.1ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% sodium dodecyl sulfate (SDS).
Cloning of the DUB-1 gene and construction of luciferase reporter plasmids. A mouse genomic library prepared in Lambda FIX II (Stratagene) was screened with the open reading frame region of the DUB-1 cDNA. The probe was labeled with [ 32 P]dCTP by the random primer method (Pharmacia), and hybridization was performed in 0.8 M NaCl-0.02 M PIPES [piperazine-N,NЈ-bis(2-ethanesulfonic acid); pH 6.5]-0.5% SDS-50% deionized formamide-100 g of denatured, sonicated salmon sperm DNA per ml for 16 h at 42ЊC. A clone encompassing the DUB-1 gene and its 5Ј and 3Ј flanking sequences was recovered as a 13-kb NotI fragment. The clone was mapped by restriction enzyme digestion and sequenced by the dideoxy DNA sequencing protocol (United States Biochemicals). A 1.5-kb SpeI-XbaI fragment from the 5Ј flanking region of DUB-1 was subcloned into the pGL2Basic plasmid (Pharmacia). The pGL2Basic plasmid contains a luciferase reporter gene without a promoter. Additional DNA fragments from the 5Ј flanking region of the DUB-1 gene were generated by PCR with pairs of 20-mer oligonucleotides designed according to the genomic DNA sequence. These fragments were subcloned into the pGL2Promoter plasmid (Pharmacia), which contains the simian virus 40 basal promoter upstream of the luciferase reporter gene.
Transient transfection and transactivation experiments. All plasmid DNAs were purified with Qiagen (Chatsworth, Calif.) columns. The indicated Ba/F3 subclones (10 7 cells per transfection) were transfected by electroporation with 10 g of test plasmid. The cells were starved by depletion of cytokine for 5 h before electroporation. After electroporation, cells were divided into pools and restimulated with the cytokines at various concentrations as indicated in the figure legends. Luciferase levels were assayed after 12 h of stimulation according to vendor specifications (with a luciferase assay kit; Analytical Luminescence Laboratory, San Diego, Calif.). Each construct was tested at least three times by independent transfection, with similar results each time.
Electrophoretic mobility shift assay. Nuclear extracts were prepared from unstimulated and IL-3-stimulated Ba/F3 cells, as previously described (1, 48) . Probe 1 (nucleotides [nt] Ϫ1528 to Ϫ1508) was synthesized as 5Ј-TAACAGGA AATAATGACTAAG-3Ј. Probe 2 (nt Ϫ1512 to Ϫ1494) was synthesized as 5Ј-CTAAGACTGTGGTATGAAG-3Ј. Probe 3 (nt Ϫ1479 to Ϫ1461) was synthesized with the sequence 5Ј-GTAGAAATGGAAAAAAAAG-3Ј. Probe 4 (nt Ϫ1455 to Ϫ1432) was synthesized with the sequence 5Ј-GGTTTCACTGCTTC ATAAGGAGAT-3Ј. The nonspecific oligonucleotide contained 20 nt which had no homology with the 112-bp enhancer element of DUB-1. The probes were end labeled with 32 P by using T4 polynucleotide kinase (Boehringer Mannheim) and annealed to the complementary strands. Unincorporated nucleotides were removed with a G-50 column (Pharmacia). Binding reaction mixtures (20 l) contained nuclear extract, 10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, pH 7.8), 65 mM NaCl, 1 mM dithiothreitol, 0.15 mM EDTA, 8% glycerol, 1 g of poly(dI-dC), and labeled DNA (1 ϫ 10 6 to 10 ϫ 10 6 cpm/pmol). Binding was for 30 min on ice. For competition analysis, unlabeled double-stranded oligonucleotides were added directly to the binding reaction mixture, as indicated in the figure legends. Samples were run for 3 h on a 5% nondenaturing polyacrylamide gel, dried, and exposed on X-ray film.
Isolation of a sequence from the DUB-3 gene, corresponding to the DUB-1 enhancer. A 243-bp fragment, corresponding to the enhancer region (nt Ϫ1657 to Ϫ1416) of the DUB-1 gene, was amplified by PCR from a genomic clone of the DUB-3 gene. The DUB-3 gene encodes a functional deubiquitinating enzyme that is highly related to DUB-1 but is not induced by IL-3 or EPO (52a). The primers utilized were 5Ј-GATTTAACAGGAATGGGCAA-3Ј and 5Ј-TCCTTA GTCACTGTTGTATCT-3Ј. The amplified DUB-3 genomic product was subcloned in pBluescript and sequenced. The 112-bp fragment derived from DUB-3 was further subcloned into pGL2Promoter. A 112-bp DUB-1 mutant fragment [DUB-1(Mut)] containing only the G-Ϫ1523-to-T mutation was generated by PCR mutagenesis and subcloned in pGL2Promoter. Enhancer activity and gel shift activity were analyzed as described above.
Detection of h␤c subunit expression. Ba/F3 cells were transfected with the cDNAs encoding full-length (wild-type) h␤c, a truncated ␤c terminating at position 544 [the ␤c(544) mutant], or the ␤c(455) mutant. Stably transfected cells were lysed, and proteins were detected by immunoblot analysis with an anti-h␤c antiserum generously provided by A. Lopez. The full-length DUB-1 cDNA probe was used to detect mRNA expression in murine cell lines and tissues (Fig. 1B) . The mRNA was detected in the IL-3-dependent early hematopoietic progenitor cell lines Ba/F3 and FDCP1 but not in the myeloid cell line 32D. Other cell lines, including MEL, CTLL, and 011 (megakaryocyte), lacked the DUB-1 mRNA (data not shown). The DUB-1 mRNA was not detected in normal adult murine tissue samples under the conditions described.
RESULTS

DUB-1 is a hematopoietic cell
Activation of the ␤c subunit of IL-3R results in induction of DUB-1 mRNA. We next tested EPO-, GM-CSF-, IL-5-, and IL-4-responsive cell lines for induction of DUB-1 mRNA. Ba/ F3-EPO-R, Ba/F3-GM-CSF-R, Ba/F3-IL-5R, or Ba/F3-IL-4R cells were starved and restimulated with the appropriate cytokines and assayed by Northern (RNA) blot analysis for the expression of endogenous DUB-1 mRNA (Fig. 2) . interacts with the ␣ chains of the IL-3R, the GM-CSF-R, and the IL-5R (12, 15, 21, 22, 27, 35) , our results suggest that DUB-1 is specifically induced by the ␤c subunit. The ␤c subunit is necessary and sufficient for the induction of DUB-1. Recent evidence suggests that the cytoplasmic regions of cytokine receptor ␣ subunits also contribute to receptor signaling (40) . For instance, the ␣ subunit of the IL-5R has a 55-amino-acid cytoplasmic region that may be required for signal transduction. In order to test the requirement for the cytoplasmic region of IL-5R␣ in DUB-1 induction, we generated a chimeric receptor (IL-5R␣-␤IL-3) that does not contain this region. The chimeric receptor contains the extracytoplasmic region of the IL-5R␣ chain and the cytoplasmic tail of murine ␤IL-3 (Fig. 3A) . This receptor forms a high-affinity IL-5 receptor with the endogenous ␤c subunit expressed in Ba/F3 cells. Stable transfection of this chimeric receptor into Ba/F3 cells conferred high-affinity murine IL-5 binding and IL-5-dependent cell growth (30a). Stimulation of Ba/F3(IL-5R␣-␤IL-3) cells with IL-3 or IL-5 resulted in induction of endogenous DUB-1 mRNA levels (Fig. 3B) , demonstrating that the ␣ subunit cytoplasmic region is not required for DUB-1 induction.
Genomic organization and 5 regulatory region of the murine DUB-1 gene. In order to understand the mechanism of cytokine-inducible transcription of DUB-1, we isolated the fulllength murine DUB-1 gene. A total of 10 6 recombinant phage were screened with the open reading frame of the DUB-1 cDNA, and four positive clones were identified. By sequence analysis, one phage clone was found to contain the full-length DUB-1 coding region (Fig. 4) . The sequence was identical to the sequence of the DUB-1 cDNA clone (53) . The other three clones contained genes with open reading frames bearing considerable homology to DUB-1 (approximately 90% base pair identity) (52a). These genes are presumably DUB subfamily members, and we refer to them as DUB-2 through DUB-4. A schematic diagram of the DUB-1 gene and a restriction map are shown in Fig. 4A . The DUB-1 gene contains a small exon (exon 1) encoding amino acids 1 to 9 and a larger exon (exon 2) encoding amino acids 10 to 526. The sequence of the intronexon junction conforms to a consensus sequence for a eukaryotic splice junction. The ATG translation start site is designated ϩ1. The 1.5-kb sequence of the DUB-1 gene, 5Ј to the ATG, was determined and is shown (Fig. 4B) . The DUB-1 cDNA clone (53) contains the sequence (Ϫ80 to ϩ1) as a 5Ј untranslated sequence. The region between positions Ϫ362 and Ϫ80 was shown to contain basic promoter activity in reporter assays (data not shown) and contains a putative TATA box at position Ϫ318. Therefore, the transcription initiation site was localized to the region between Ϫ318 and Ϫ80. (Fig. 5) . Luciferase activity was increased in a dose-dependent manner by IL-3, GM-CSF, and IL-5 but not by hIL-4 or EPO. In addition, luciferase activity was not increased by alpha interferon or gamma interferon, despite the expression of functional interferon receptors on Ba/F3 cells (data not shown). For all Ba/F3 subclones, no luciferase activity was induced when the vector alone was transfected (data not shown). Taken together, these data verify that activation of the ␤c subunit is required for induction of the DUB-1 gene. In addition, the results demonstrate that the 1.5-kb 5Ј flanking region of the DUB-1 gene contains a functional promoter and regulatory elements that mediate ␤c-dependent transcriptional activation.
Identification of a minimal ␤c-responsive enhancer element. To further delineate the specific DNA element required for IL-3 induction, we next divided the 1.5-kb region into several DNA fragments (Fig. 6) . Each fragment was subcloned into the vector pGL2Promoter, which contains the luciferase gene driven by a simian virus 40 basic promoter without an enhancer (Fig. 6A) . The fragments T14P11/18, T14P17/20, and T14P11/21 had IL-3-dependent enhancer activity (Fig. 6B) . Stimulation of cells with 10 pM IL-3 resulted in three-to fourfold-higher levels of luciferase activity than that produced by stimulation with 1 pM IL-3. Stimulation of cells with EPO resulted in no increased luciferase activity (data not shown). The fragments T14P14/17, T14P16/13, and T14P12/18 had no enhancer activity. Since the three fragments overlapped the region from Ϫ1541 to Ϫ1416, this region (125 bp) was initially identified as a ␤c-specific, inducible enhancer.
We next performed further truncations of the DUB-1 enhancer region (Fig. 7) . A region of 112 bp (B1NC21), corresponding to bp Ϫ1528 to Ϫ1416, had activity comparable to that of the T14p11/21 fragment. Further truncations within this region generated DNA fragments with only partial activities. For instance, the B1B2 fragment (5Ј end) demonstrated enhancer activity that was 9% of the activity of the T14p11/21 fragment. The B2NC21 fragment (3Ј end) had enhancer activity that was 14% of the activity of the T14p11/21 fragment. VOL. 16, 1996 INDUCTION OF THE DUB-1 GENE 4811
on February 23, 2013 by PENN STATE UNIV http://mcb.asm.org/ These data suggest that the 112-bp fragment is the minimal region required for ␤c-specific DUB-1 induction. This fragment was not activated by EPO or IL-4 stimulation (data not shown). The 112-bp sequence (Fig. 4B ) may, therefore, contain a novel ␤c-specific transcriptional activation element. Specific binding of inducible and noninducible protein complexes to the ␤c-responsive DUB-1 enhancer element. In order to determine if regulatory proteins bind to the DUB-1 enhancer, we constructed four double-stranded oligonucleotides from the minimal enhancer region (Fig. 8A) . Initially, probe 1, derived from the 5Ј end of the minimal enhancer (Ϫ1528 to Ϫ1508), was end labeled with 32 P and used in a gel mobility shift assay to determine protein binding (Fig. 8B) . Interestingly, two major gel shift complexes were identified in nuclear extracts from IL-3-stimulated cells. The complexes were inhibited by unlabeled probe 1 (S) but not by a nonspecific oligonucleotide (NS). These data demonstrate that specific, inducible protein complexes bind to the 5Ј region of the 112-bp DUB-1 enhancer. However, it is not clear whether these two complexes are related.
Probe 3, derived from the 3Ј region of the minimal enhancer (Ϫ1479 to Ϫ1461), was labeled with 32 P and used to identify additional protein complexes (Fig. 8C) . Another protein complex was identified from both unstimulated and IL-3-stimulated cells. This noninducible protein complex was inhibited by unlabeled probe 3 (S) but not by a nonspecific oligonucleotide (NS). Probe 2 and probe 4 did not reveal significant protein complexes by gel shift analysis (data not shown). Taken together, these data demonstrate binding of two discrete protein complexes, one to the 5Ј region and one to the 3Ј region of the minimal enhancer. Both complexes may be needed for functional enhancer activity in vivo.
Specific sequences required for DUB-1 enhancer activity. In order to identify specific base pairs within the DUB-1 enhancer required for ␤c responsiveness, we next compared the DUB-1 enhancer with an analogous region of the DUB-3 gene (Fig. 9) . The DUB-3 gene was isolated during our genomic screening for the DUB-1 gene (52b). The DUB-1 and DUB-3 genes encode functional deubiquitinating enzymes that are highly homologous throughout their primary amino acid sequences; however, the DUB-3 mRNA is not induced by IL-3 or EPO. We reasoned that differences in the upstream regulatory sequences of DUB-1 and DUB-3 might account for differences in transcriptional activation. The analogous 5Ј enhancer region of the DUB-3 gene differed from the DUB-1 minimal enhancer region by only 6 bp at five positions (Fig. 9A) . A G-to-T mutation fell within probe 1, and a double-A insertion fell within probe 3. These base pair alterations of the DUB-3 enhancer region ablated IL-3-dependent enhancer activity (Fig.  9B) . In order to assess the importance of these base pair changes in the binding of the specific protein complexes, we tested the activity of mutant probe 1 or probe 3 in gel shift assays. IL-3 induced the formation of two protein complexes that bind to 32 P-labeled probe 1 (Fig. 9C, lane 3) . Interestingly, these complexes were inhibited by wild-type (Fig. 9C, lane 4) but not mutant (lane 5) probe 1. In contrast, the specific protein complex that binds to probe 3 (Fig. 9D, lanes 2 and 3) was inhibited by both wild-type (lane 4) and mutant (lane 5) probe 3. These data demonstrated that residue G-Ϫ1523 is required for the binding of the IL-3-inducible complexes. This residue falls within an ETS-like consensus sequence (Fig. 9A) (29) . In accordance with these data, the 112-bp element which contains the mutation of G-Ϫ1523 to T, DUB-1(Mut), ablates ␤c-responsive enhancer activity (Fig. 9B) .
The membrane-proximal region of the ␤c subunit is required for activation of the DUB-1 enhancer. In order to identify regions of the ␤c cytoplasmic tail required for DUB-1 induction, we next assayed various truncated mutants of the h␤c subunit (Fig. 10) . Initially, we generated a Ba/F3 subclone stably expressing the hGM-CSF-R␣ subunit. These cells grow in murine IL-3 but do not grow in hGM-CSF. When these cells were next transfected with the cDNA encoding the wild-type h␤c subunit, the resulting cells (Ba/F3-hGM-CSF-R␣-h␤c cells) grew in either murine IL-3 or hGM-CSF. These data are in accordance with previous studies (15) that report a functional interaction between the hGM-CSF-R-␣ chain and the h␤c chain.
In addition, Ba/F3-hGM-CSF-R-␣ cells were stably transfected with cDNAs encoding a truncated ␤c mutant terminating at amino acid 544, ␤c(544), or a truncated ␤c mutant terminating at amino acid 455, ␤c(455) (45, 46) (Fig. 10A) . To ensure that the ␤c mutant polypeptides were expressed, we performed an immunoblot analysis with an anti-h␤c antibody (Fig. 10B) . Wild-type, ␤c(544), and ␤c(455) polypeptides were also expressed on the surfaces of the respective Ba/F3 subclones, as demonstrated by fluorescence-activated cell sorter analysis (data not shown).
The respective Ba/F3 clones were transfected with the B1NC21-luc construct, which contains the minimal enhancer region, and assayed for cytokine-inducible luciferase activity (Fig. 10C) . As a positive control for each Ba/F3 subclone, luciferase activity induced by murine IL-3 was determined. Luciferase activity induced by hGM-CSF via the wild-type ␤c subunit was similar to activity induced by murine IL-3. Luciferase activity induced by the ␤c(544) mutant was 50% of the activity induced by murine IL-3. Luciferase activity induced by the ␤c(455) mutant was 2% of the activity induced by murine IL-3 and was equivalent to that of the unstimulated control. Taken together, these results confirm that the h␤c subunit, like VOL. 16, 1996 INDUCTION OF THE DUB-1 GENE 4813
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DISCUSSION
We have isolated an immediate-early gene, DUB-1, that is specifically induced by the cytokines IL-3, IL-5, and GM-CSF but not by EPO and IL-4. Since IL-3R, IL-5R, and GM-CSF-R share the ␤c subunit, we hypothesize that ␤c generates a specific signal for DUB-1 induction. In addition, transient transfection experiments utilizing DUB-1 promoter-luciferase plasmids delineated a 112-bp minimal enhancer region required for ␤c responsiveness. To further confirm the importance of the ␤c subunit, we utilized truncated forms of h␤c. The proximal membrane region of ␤c was necessary and sufficient for DUB-1 transcriptional activation. Taken together, these data demonstrate that a specific signaling mechanism, activated by the ␤c subunit, can induce transcription of DUB-1.
DUB-1 is the first example of an immediate-early gene that is specifically induced by the ␤c subunit. Previous studies have identified immediate-early genes inducible by IL-3 (49, 52) , but these genes were induced by other cytokines as well. Recently, Beadling et al. (4) identified immediate-early genes that were specifically induced by IL-2. Otherwise, there are few examples of cytokine-specific, immediate-early genes.
The possible cellular function of a ␤c-specific inducible gene remains unclear. IL-3, IL-5, and GM-CSF, on the one hand, induce cellular proliferation of early hematopoietic progenitor cells. EPO, on the other hand, is a lineage-specific growth factor that induces both cellular proliferation and differentiation (25) . Our results suggest that DUB-1 expression may play a role in the sustained proliferation of IL-3-, GM-CSF-, or IL-5-responsive cells. The DUB-1 gene product is selectively expressed in the early G 1 phase of the cell cycle, following ␤c stimulation. Misregulated expression of DUB-1 results in G 1 phase arrest (53) . These results suggest that the DUB-1 protein couples ␤c stimulation to cell cycle progression, probably via the ubiquitin-mediated proteolytic pathway.
The DUB-1 enhancer is the first example of an enhancer that is specifically activated by a specific subunit of a cytokine receptor. Deletion analysis identified a minimal enhancer region of 112 bp. Attempts to further truncate the 112-bp enhancer region resulted in significant loss of activity (Fig. 7) . Consistent with these observations, the 112-bp region demonstrates at least two specific protein complexes, one at its 5Ј end and one at its 3Ј end (Fig. 8) . Interestingly, the 5Ј complex is inducible by a ␤c signaling pathway. These data suggest that efficient enhancer activity requires both binding complexes in vivo. Other examples of complex enhancers containing multiple regulatory elements have been described (7, 33) . Binding of the two protein complexes to the DUB-1 enhancer correlates with transcription of DUB-1. For instance, 32D cells do not exhibit the protein complexes (data not shown) and do not express DUB-1 mRNA (Fig. 1B) .
In order to identify specific base pairs within the DUB-1 enhancer required for ␤c responsiveness, we have compared the DUB-1 enhancer with an analogous region of the DUB-3 gene which is not ␤c inducible. A similar approach of comparing inducible elements of mouse interferon-inducible genes has previously been reported (13) . The DUB-1 enhancer and the analogous DUB-3 sequence differed by only 6 bp. Interestingly, one of these base pair alterations, G-Ϫ1523 to T, ablated binding of the IL-3-inducible protein complex and eliminated IL-3-inducible enhancer activity.
The specific DNA-binding proteins constituting the two protein complexes of the DUB-1 enhancer remain unknown. The (B) Nuclear extracts were prepared from either unstimulated (Ϫ) or IL-3 (10 pM)-stimulated (ϩ) Ba/F3 cells, and a gel shift assay was performed with radiolabeled probe 1. In lane 1, no extract was used. In lanes 4 and 5, 500-fold molar excesses of unlabeled probe 1 (S) and double-stranded nonspecific oligonucleotide (NS), respectively, were used for competition in the binding reactions. (C) Nuclear extracts were prepared from either unstimulated or stimulated Ba/F3 cells, and gel shift was performed with radiolabeled probe 3. In lane 1, no extract was used. In lanes 4 and 5, 500-fold molar excesses of unlabeled probe 3 (S) and double-stranded nonspecific oligonucleotide (NS), respectively, were used for competition. Specific protein complexes are indicated with arrows. FP, free (unbound) probe. Luciferase assays were performed after 12 h. (C) Nuclear extracts were prepared from unstimulated (Ϫ) or IL-3-stimulated (ϩ) Ba/F3 cells, and a gel shift assay was performed with radiolabeled probe 1. In lane 1, no extract was used. In lanes 4 to 6, 500-fold molar excesses of unlabeled probe 1 (S), mutant probe 1 (Mut), and nonspecific oligonucleotide (NS), respectively, were used for competition. Mutant probe 1 contains the G-Ϫ1523-to-T mutation indicated in panel A. (D) Nuclear extracts were prepared from unstimulated or IL-3-stimulated Ba/F3 cells, and a gel shift assay was performed with radiolabeled probe 3. In lane 1, no extract was used. In lanes 4 to 6, 500-fold molar excesses of unlabeled probe 3 (S), mutant probe 3 (Mut), and nonspecific oligonucleotide (NS), respectively, were used for competition. The mutant probe 3 contains the mutation indicated in panel A. FP, free (unbound) probe.
DUB-1 112-bp minimal enhancer contains candidate binding sequences (Fig. 9A) . The sequence contains an ETS protein consensus (29, 47) (nt Ϫ1524 to Ϫ1516), an AP-1 site (29) (nt Ϫ1515 to Ϫ1509), two GATA sites (43) (nt Ϫ1483 to Ϫ1480 and Ϫ1461 to Ϫ1458), a CBF site (34) (nt Ϫ1505 to Ϫ1498), and a TG protein binding site (13) (nt Ϫ1476 to Ϫ1467). The CBF site located on probe 2 does not demonstrate a significant gel shift. Whether any of these proteins contributes to the complexes remains unknown. Interestingly, the ETS consensus sequence is disrupted by the G-Ϫ1523-to-T mutation, suggesting the possibility that the inducible protein complex contains an ETS family member. No members of the ETS family of transcription factors are known to be cytokine inducible.
Finally, we have demonstrated that the membrane-proximal region of ␤c, containing amino acids 455 to 544, is required for induction of the DUB-1 gene. This region of ␤c has previously been shown to activate the JAK-STAT pathway and the c-myc induction pathway (45, 46) , suggesting that these pathways may play a role in DUB-1 induction. In contrast, the Ras-Raf-MAP kinase pathway is activated by the distal region of the ␤c receptor. This region is therefore not required for full induction of DUB-1 transcription but may partially contribute to DUB-1 induction.
Although activation of the JAK-STAT pathway by the proximal domain of ␤c correlates with DUB-1 induction, the JAK-STAT pathway alone cannot account for the specificity of DUB-1 induction. For instance, both IL-3 and EPO activate STAT5A and STAT5B yet EPO does not induce DUB-1. In addition, no STAT binding elements (10) are found in the 112-bp enhancer region of the DUB-1 gene. Taken together, these observations suggest that additional levels of specificity must be activated by the ␤c subunit. For instance, the ␤c subunit may activate an additional unique signaling pathway, such as one recently described (39) . Further analysis of the DUB-1 enhancer and its DNA-binding proteins may reveal specific determinants of a ␤c-specific signaling pathway.
